Approval · Notice of Compliance 13098 · 2012
CAMBIA: Notice of Compliance 13098
Issued March 14, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13098
- Date
- March 14, 2012
- Company
- Tribute Pharmaceuticals Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Nonsteroidal Anti-inflammatory Drug (NSAID)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CAMBIA | 02381680 | Marketed |
Medicinal ingredients
- DICLOFENAC POTASSIUM 50 MG per PAD